Invitro & Invivo Diagnostic

New Alpha Radiopharmaceutical Imaging Platform Aims to Improve In Vivo Therapy Visualisation

α-Sight™ integrates advanced SPECT imaging, radiochemistry, and quantitative analysis to enable precise tracking of alpha-emitting therapies...

FertilAI Secures CE Mark for Predictive AI in Fertility Treatment Optimisation

AI will soon enable clinicians to predict ovulation and optimize IVF cycle timing, improving outcomes and operational efficiency....

Cepheid And Oxford Nanopore Expand Partnership To Advance Rapid Genomic Workflow For Sepsis Research

Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research...

Invivoscribe Elevates Molecular Diagnostics With PrepQuant System To Standardise And Accelerate Sample Preparation

Integrated automated platform unifies multi step sample preparation to improve consistency, reduce operational complexity, and enable high precision workflows across MRD testing and advanced molecular diagnostics...

Premier Radiology Services Acquires Global Imaging Solutions

These strengths enhance our platform and position us to meet the growing demand for high-quality teleradiology services in outpatient imaging...

Advancing Global Diagnostics with Expanded Immunoassay Testing Solutions

QuidelOrtho is strengthening its global immunoassay offering through a new partnership aimed at expanding assay availability beyond its existing VITROS diagnostic system portfolio...

Thermobalancing therapy emerges as drug-free option for BPH

The key defining features of Thermobalancing therapy are its high treatment efficacy and no side effects...

JLL Partners Acquires Vascular Diagnostics Firm Parks Medical

Parks Medical continues to be a trusted partner to healthcare professionals and organisations worldwide...

2025 Biological Device Application Approvals. How FDA Clearances Are Reshaping Blood Banking, Diagnostics, and Point of Care Medicine

From blood bank software and immunohematology analysers, to HIV diagnostics and platelet rich plasma systems, the 2025 approval landscape signals a clear shift towards automation, safety, traceability, and point of care innovation across transfusion and laboratory medicine...

QuidelOrtho Expands QUICKVUE Portfolio with FDA-Cleared Influenza + SARS Rapid Test

The new CLIA-waived immunoassay enables simultaneous detection of influenza A/B and SARS-CoV-2 in just 10 minutes, supporting faster, cost-effective decision-making at the point of care....